20-F XBRL

ANNUAL REPORT

Company: Quoin Pharmaceuticals, Ltd.
Filed: April 3, 2020
Period of Report: December 31, 2019
Accession Number: 0001213900-20-008493

View Document ↗ View on SEC.gov ↗